NJ Firm In-Licenses Israeli Seaweed Technology to Treat Heart Attack

A new heart-healing gel based on brown seaweed has just been rewarded with a record investment deal.  The Israeli company BioLineRx, founded in 2003, just released the news that one if its two compounds – the BL-1040 – to repair damaged heart muscles after cardiac arrest, has been licensed by the New Jersey-based company Ikaria Holdings in a $282.5 million deal, confirms a BioLineRx representative, Dganit Bar.

More info